Search

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

For any organization, one ill-timed tweet can create enormous backlash.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

Sitting Down With… Gen Li, CEO, Phesi

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?